Roopika Menon

Roopika Menon

Auto-generated profile, based on publicly available information

Roopika Menon

NEO New Oncology GmbH, Cologne, Germany

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2018 in Science
Verified
Journal Article
Closed access
PDF file
SASandra Ackermann
Sandra Ackermann
MCMaria Cartolano
Maria Cartolano
BHBarbara Hero
Barbara Hero
AWAnne Welte
Anne Welte
YKYvonne Kahlert
Yvonne Kahlert
MFMatthias Fischer
Matthias Fischer
A systematic look at a childhood tumor: Neuroblastomas—the most common tumor type in infants—develop from fetal nerve cells, and their clinical course is highly variable. Some neuroblastomas are fatal despite treatment, whereas others respond well to treatment and some undergo spontaneous regression without treatment. Ackermann et al. sequenced more than 400 pretreatment neuroblastomas and identified molecular features that characterize the three distinct clinical outcomes. Low-risk tumors lack telomere maintenance mechanisms, intermediate-risk tumors harbor telomere maintenance mechanisms, and high-risk tumors harbor telomere maintenance mechanisms in combination with RAS and/or p53 pathway mutations. Science , this issue p. 1165

25 November 2020 in Virchows Archiv
Verified
Journal Article
Open access
PDF file
HMHanna Majewska
Hanna Majewska
AGAdam Gorczyński
Adam Gorczyński
PCPiotr Czapiewski
Piotr Czapiewski
RMRoopika Menon
Roopika Menon
JMJudith Mueller
Judith Mueller
?B????Wojciech Biernat
????Wojciech Biernat
Salivary gland carcinomas represent a heterogeneous group of poorly characterized head and neck tumors. The purpose of this study was to evaluate ALK gene and protein aberrations in a large, well-characterized cohort of these tumors. A total of 182 salivary gland carcinomas were tested for anaplastic lymphoma kinase (ALK) positivity by immunohistochemistry (IHC) using the cut-off of 10% positive cells. ALK positive tumors were subjected to FISH analysis and followed by hybrid capture–based next generation sequencing (NGS). Of the 182 tumors, 8 were ALK positive by IHC. Further analysis using hybrid capture NGS analysis revealed a novel MYO18A (Exon1-40)-ALK (exon 20-29) gene fusion in one case of intraductal carcinoma. Additional genomic analyses resulted in the detection of inactivating mutations in BRAF and TP53, as well as amplifications of ERBB2 and ALK. ALK rearrangements are a rare entity in salivary gland carcinomas. We identified a potentially targetable novel ALK fusion in an intraductal carcinoma of minor salivary glands.



3 April 2023
Verified
Other
Open access
BDBenjamin J. Drapkin
Benjamin J. Drapkin
JGJulie George
Julie George
CCCamilla L. Christensen
Camilla L. Christensen
MMMari Mino-Kenudson
Mari Mino-Kenudson
RDRuben Dries
Ruben Dries
AFAnna F. Farago
Anna F. Farago
Text for supplement: Supplementary methods, supplementary figure legends